TELA · TELA Bio, Inc.
$0.64
-0.03 (-4.97%)
At close · Aug 14
Going-concern doubt
— flagged Aug 11, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions and events raise substantial doubt about the Company's ability to continue as a going concern within one year after the date these consolidated financial statements are issued. Accordingly, management has concluded that substantial doubt exists about the Company's ability to continue as a going concern within one year after the date these consolidated financial statements are issued.”View the 10-Q filed Aug 11, 2026
Market Cap
$28.93M
Shares
44.89M
Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.
Model estimate
Expected Aug 14 short interest
as of Aug 14
357,275
+4.6% vs reported
Short Squeeze Score
56/100
Short interest 0.8% of shares — P38
Days to cover 10.5 — P90
Price vs VWAP -22.7% — P11
Short-volume trend +11.5% — P86
Short interest change -5.6% — P37
Worst FTD 0.24% of shares — P86
Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-07-31). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.
Short Interest History
| Settlement Date | Current Position | Previous Position | Change | Days to Cover |
|---|---|---|---|---|
|
2026-08-31
Scheduled
FINRA publishes Sep 10
|
— | — | — | — |
|
2026-08-14
Scheduled
FINRA publishes Aug 25
|
— | — | — | — |
| 2026-07-31 | 341,493 | 361,787 | -20,294 | 10.49 |
| 2026-07-15 | 361,787 | 466,218 | -104,431 | 4.96 |
| 2026-06-30 | 466,218 | 302,880 | +163,338 | 3.94 |
| 2026-06-15 | 302,880 | 748,090 | -445,210 | 2.65 |
| 2026-05-29 | 748,090 | 787,044 | -38,954 | 7.29 |
| 2026-05-15 | 787,044 | 765,765 | +21,279 | 2.50 |
| 2026-04-30 | 765,765 | 756,594 | +9,171 | 4.23 |
| 2026-04-15 | 756,594 | 690,940 | +65,654 | 4.56 |
| 2026-03-31 | 690,940 | 577,693 | +113,247 | 2.89 |
| 2026-03-13 | 577,693 | 629,667 | -51,974 | 11.33 |
| 2026-02-27 | 629,667 | 644,626 | -14,959 | 7.24 |
| 2026-02-13 | 644,626 | 508,384 | +136,242 | 1.08 |
| 2026-01-30 | 508,384 | 475,809 | +32,575 | 8.31 |
| 2026-01-15 | 475,809 | 475,554 | +255 | 7.97 |
| 2025-12-31 | 475,554 | 448,743 | +26,811 | 4.39 |
| 2025-12-15 | 448,743 | 426,141 | +22,602 | 3.18 |
| 2025-11-28 | 426,141 | 416,541 | +9,600 | 1.00 |
| 2025-11-14 | 416,541 | 485,110 | -68,569 | 1.79 |
| 2025-10-31 | 485,110 | 423,763 | +61,347 | 4.02 |
| 2025-10-15 | 423,763 | 365,400 | +58,363 | 5.59 |
| 2025-09-30 | 365,400 | 413,665 | -48,265 | 3.15 |
| 2025-09-15 | 413,665 | 423,743 | -10,078 | 5.52 |
| 2025-08-29 | 423,743 | 460,503 | -36,760 | 4.72 |
Showing 1–23 of 23 settlements
Key facts
CIK
1561921
CUSIP
872381108
13F (30d)
46 filings
44 filers
Visit website
Investor relations